Company News in the Life Science Industry

»

Reset 

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

NEW YORK, March 19, 2019 /PRNewswire/ -- Report Scope:
The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents, and companies. The market sizes for liquid biopsy diagnostics are given... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019

Intravenous-to-Subcutaneous Drug Repositioning

NEW YORK, March 19, 2019 /PRNewswire/ -- As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019

The Inception Company Partners with WEGO Health to Launch a Virtual Patient Collaboration Platform via Pando(TM)

FAIRFIELD, N.J., March 19, 2019 /PRNewswire/ -- The Inception Company, a technology-driven production company, and WEGO Health, the premiere network of patient opinion leaders and health influencers, today announced the launch of "Patient Co-Lab."

Read more ››
By: PR Newswire Association LLC. - 19 Mar 2019

Provention Bio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

OLDWICK, N.J., March 19, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Provention Bio, Inc

Evolution Research Group Names New COO and CBO

NEW PROVIDENCE, N.J., March 19, 2019 /PRNewswire/ -- Evolution Research Group, LLC (ERG), one of the leading, privately held, independent clinical research site companies in the U.S. with an expertise in early- and late-stage neuroscience drug development, has announced the promotion of Andria... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Foundation for Applied Molecular Evolution (FfAME) | Evolution Research Group | Health Evolution Partners | EVOLUTION Life Science Partners

Nevro Announces New CEO, Board Appointments and Agreement with Broadfin Capital

REDWOOD CITY, Calif., March 19, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO) ("Nevro"), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman has been appointed President and Chief Executive... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Nevro Corp.

Actinium Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Highlights

NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) reported its financial results for the fourth quarter and year ended December 31, 2018 as well as provided corporate and operational updates on clinical trials, research and development, recent... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Actinium Pharmaceuticals, Inc.

PolarityTE to Present at Oppenheimer 29th Annual Healthcare Conference

SALT LAKE CITY, March 19, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) announced today that it will attend and present at the Oppenheimer 29(th) Annual Healthcare Conference on March 20, 2019 in New York City. PolarityTE is a commercial-stage biotechnology company focused... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  PolarityTE™, Inc.

Actinium Appoints Accomplished FDA and Industry Professional Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs

NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today the appointment of Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs. In this role, Dr. Gokhale will be responsible for developing and implementing a comprehensive... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  Actinium Pharmaceuticals, Inc.

Smithsonian Examines Health and Medicine Through Philanthropy Lens

WASHINGTON, March 19, 2019 /PRNewswire/ -- Philanthropy to support health and medicine is the focus of the updated exhibit "Giving in America" at the Smithsonian's National Museum of American History. Donations from The Estée Lauder Companies Archives and the Breast Cancer Research Foundation... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019

FDA approves first treatment for postpartum depression

SILVER SPRING, Md., March 19, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

Read more ››
By: PR Newswire Association LLC. - 19 Mar 2019
Related companies:  U.S. Food and Drug Administration

The antihypertensive drugs market will register a CAGR of over 2% by 2023

NEW YORK, March 19, 2019 /PRNewswire/ -- About this market
Patients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing... Read more ››

By: PR Newswire Association LLC. - 19 Mar 2019

Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808 for Acromegaly

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Crinetics Pharmaceuticals, Inc.

BLOCKStrain: Three Target Markets, One Breakthrough Platform -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019

Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Onconova Therapeutics, Inc.

ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson’s Disease at AD/PD™ 2019 Conference

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  ProMIS Neurosciences, Inc.

Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Innovate Biopharmaceuticals, Inc.

Teladoc Health to Expand Global Reach with Acquisition of MédecinDirect

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Teladoc, Inc.

Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019

Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA

Read more ››
By: Nasdaq / GlobenewsWire - 19 Mar 2019
Related companies:  Innovative Cellular Therapeutics Co.,Ltd. (also known as SiDanSai Biotechnology Co., Ltd.)
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies